This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Stanford Graduate School of Business (USA)
-
Invitrogen (A)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209A-EStrategyFounded in 1987, Invitrogen was one of the largest catalog life science companies in the industry. Its customers came from academic research, biotechnology and pharmaceutical companies and government laboratories. Scientists viewed Invitrogen as a one-stop shop for all major molecular biology, biochemistry and cell culture reagent products, with prices ranging from a hundred dollars to a few thousand dollars.Starting at €8.20
-
Invitrogen/Life Technologies (B)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209B-EStrategyOn June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.Starting at €5.74
-
Sand Hill Angels: To Fund or Not to Fund
Strbulaev, I; Han, ACase SGSB-E442-EEntrepreneurshipAngel investment in new technology firms has grown in prominence and popularity in the 21st century, particularly in the Silicon Valley. This case reviews the landscape of angel investors, describes the decision making process of an angel consortium operating in the Silicon Valley, and provides profiles of: three actual members of the angel consortium and four real investment opportunities reviewed by the group. Instructors may use the profiles t...Starting at €8.20
-
Broadway Angels: Preparing for the Future
Strbulaev, I; QuiglessMCase SGSB-E531-EEntrepreneurshipThe Broadway Angels investment group represents one of the few women-run angel groups in Silicon Valley. The group was founded by some of the most illustrious investors and operators with the mission to generate strong returns to members and inspire women in tech and investing. The case begins during the April 2014 investment meeting of the Broadway Angels. The members are evaluating an investment in Other Machine Co (OMC) and contemplating th...Starting at €8.20
-
Invitrogen/Life Technologies (C): The "Best Owner" of the Asset
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209C-EStrategyThis short case discusses the process of Life Technologies’ acquisition by Thermo Fisher in 2013 and 2014. The case is a complement to SM-209A and SM-209B, which highlight the various growth and acquisition strategies the company undertook over the previous 10 years.Starting at €5.74